The Pennington Biomedical Research Foundation is looking for a new president and CEO after its former top exec left quietly eight months ago.
The board overseeing the foundation—formed in 1987 to raise money for LSU’s Pennington Biomedical Research Center—hired Carol Dreher in May 2015, citing her fundraising background. Dreher left the post last October, and no explanation for her departure has been made public.
Bill Silvia, president and CEO of the Pennington Medical Foundation—a separate entity—stepped in to lead the research foundation in the interim. Now Silvia is retiring and will lead a search for his replacement. He expects to have a handful of candidates to bring to the board by August.
Staffers and board members reached by Daily Report declined to discuss the circumstances surrounding Dreher’s exit, citing a policy of not discussing personnel matters. Dreher also declined to comment. J. Gerard Jolly, the chairman of the board at the time of Dreher’s hiring, said “she did a good job while she was there.”
Before joining the foundation, Dreher worked at a biotech startup in Washington, D.C., called QioMed.
The Pennington Medical Foundation essentially operates as a trust fund dedicated to the similarly named LSU research center, while the Pennington Biomedical Research Foundation—the organization Dreher led—is the fundraising arm, according to Silvia. There is also an organization called the Pennington Foundation that raises money for a broader range of initiatives and groups.
Silvia, who worked as a vice president at LSU for 20 years, has filled in sporadically over the years as head of the Pennington Biomedical Research Foundation. He began working as CEO of the Pennington Medical Foundation in 2006 and has been running both organizations since October. Silvia says he helped found the research foundation in 1987.
The research foundation has two other soon-to-be-vacant positions: director of leadership giving and director of advancement services. Employees currently in those positions are leaving the organization, Silvia says.
Although Silvia is retiring from the Pennington Medical Foundation, no search for a replacement is underway, as the new CEO of the Pennington Research Foundation may fill both roles.
“I don’t see any philosophical switches,” he says of the staff shakeup at the foundation. “I’ve just been around a long time.”
In recent years, the foundation has tried to expand its fundraising efforts nationally. The Pennington Biomedical Research Center is focused on nutrition-based research and has 10 research areas, including obesity, diabetes, genetics and cancer.
—Sam Karlin
